Repurposed ethoxzolamide reprograms antitumor immunity through beta-TrCP-dependent PD-L1 ubiquitination. (linkinghub.elsevier.com)

Authors: Lin X … Xue X Journal: Cell Reports Medicine Published: 2026-07-13 DOI: https://doi.org/10.1016/j.xcrm.2026.102920